Showing results (151-160 of 225) with videos related to
Sort By:
Pageof 23
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 24, 2020
The use of biotelemetry to explore disease progression markers in amyotrophic lateral sclerosisMadeline Kelly, Arseniy Lavrov, Luis Garcia-Gancedo, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 8, 2014
Predictors of cognitive impairment in an early stage Parkinson's disease cohortMichele T M Hu, Konrad Szewczyk-Królikowski, Paul Tomlinson, et al.Acta Neuropathologica Communications|July 4, 2020
Quantitative patterns of motor cortex proteinopathy across ALS genotypesMatthew Nolan, Connor Scott, Menuka Pallebage Gamarallage, et al.Stem Cell Reports|June 14, 2024
Cellular and axonal transport phenotypes due to the C9ORF72 HRE in iPSC motor and sensory neuronsJakub Scaber, Iona Thomas-Wright, Alex J Clark, et al.Cell Reports|October 31, 2019
Interaction of Axonal Chondrolectin with Collagen XIXa1 Is Necessary for Precise Neuromuscular Junction FormationAna-Maria Oprişoreanu, Hannah L Smith, Sukrat Arya, et al.JMIR Mhealth and Uhealth|December 21, 2019
Objectively Monitoring Amyotrophic Lateral Sclerosis Patient Symptoms During Clinical Trials With Sensors: Observational StudyLuis Garcia-Gancedo, Madeline L Kelly, Arseniy Lavrov, et al.Journal of Lipid Research|November 5, 2016
Defective cholesterol metabolism in amyotrophic lateral sclerosisJonas Abdel-Khalik, Eylan Yutuc, Peter J Crick, et al.Acta Neuropathologica Communications|September 26, 2018
Neurodegeneration in SCA14 is associated with increased PKCγ kinase activity, mislocalization and aggregationMaggie M K Wong, Stephanie D Hoekstra, Jane Vowles, et al.Neurobiology of Disease|October 6, 2018
Single-copy expression of an amyotrophic lateral sclerosis-linked TDP-43 mutation (M337V) in BAC transgenic mice leads to altered stress granule dynamics and progressive motor dysfunctionDavid Gordon, Ruxandra Dafinca, Jakub Scaber, et al.Molecular Therapy. Nucleic Acids|February 12, 2021
Targeting the 5' untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophyAudrey M Winkelsas, Christopher Grunseich, George G Harmison, et al.Pageof 23